{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:38:08Z","timestamp":1768293488423,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lidocaine is a local anesthetic that is sometimes administered in combination with epinephrine. The addition of epinephrine increases the time lidocaine remains at the site of administration, thus prolonging the duration of effect. Due to their potential to prevent the visual detection of lameness, the administration of local anesthetics is strictly regulated in performance and racehorses. Recent reports of positive regulatory findings for lidocaine in racehorses suggests a better understanding of the behavior of this drug is warranted. The objective of the current study was to describe serum and urine concentrations and the pharmacokinetics of lidocaine and its primary metabolites following administration in combination with epinephrine, as a palmar digital nerve block in horses. Twelve horses received a single administration of 1 mL of 2% lidocaine HCl (20\u00a0mg\/horse) with epinephrine 1:100,000, over the palmar digital nerve. Blood samples were collected up to 30\u00a0h and urine samples up to 48\u00a0h post administration. Lidocaine and metabolite concentrations were determined by liquid chromatography- mass spectrometry and pharmacokinetic (non-compartmental and compartmental) analysis was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum concentrations of lidocaine and 3-hydroxylidocaine were above the LOQ of the assay at 30\u00a0h post administration and monoethylglycinexylidide (MEGX) and glycinexylidide (GX) were below detectable levels by 24 and 48\u00a0h, respectively. In urine, lidocaine, MEGX and GX were all non-detectable by 48\u00a0h post administration while 3-hydroxylidocaine was above LOQ at 48\u00a0h post administration. The time of maximal concentration for lidocaine was 0.26\u00a0h (median) and the terminal half-life was 3.78\u00a0h (mean). The rate of absorption (Ka) was 1.92 1\/h and the rate of elimination (Kel) was 2.21 1\/h.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared to previous reports, the terminal half-life and subsequent detection time observed following administration of lidocaine in combination with epinephrine is prolonged. This is likely due to a decrease in systemic uptake of lidocaine because of epinephrine induced vasoconstriction. Results of the current study suggest it is prudent to use an extended withdrawal time when administering local anesthetics in combination with epinephrine to performance horses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-023-03787-x","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:02:40Z","timestamp":1698649360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics and metabolism of lidocaine HCl 2% with epinephrine in horses following a palmar digital nerve block"],"prefix":"10.1186","volume":"19","author":[{"given":"Heather K.","family":"Knych","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Katzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"McKemie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Blea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"issue":"2","key":"3787_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2344\/0003-3006-59.2.90","volume":"59","author":"DE Becker","year":"2012","unstructured":"Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesth Prog. 2012;59(2):90\u2013102.","journal-title":"Anesth Prog"},{"key":"3787_CR2","unstructured":"Vickroy TW. Local anesthetics. In J.E. Riviere & M.G. Papich 9Eds.), Veterinary Pharmacology & Therapeutics. 10th ed. Wiley Blackwell; 2018."},{"issue":"10","key":"3787_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.2460\/ajvr.79.10.1028","volume":"79","author":"AV Alvarez","year":"2018","unstructured":"Alvarez AV, Schumacher J, DeGraves FJ. Effect of the addition of epinephrine to a lidocaine solution on the efficacy and duration of palmar digital nerve blocks in horses with naturally occurring forefoot lameness. Am J Vet Res. 2018;79(10):1028\u201334.","journal-title":"Am J Vet Res"},{"issue":"4","key":"3787_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/00000542-199910000-00015","volume":"91","author":"CM Bernards","year":"1999","unstructured":"Bernards CM, Kopacz DJ. Effect ofeEpinephrine on lidocaine clearance in vivo: a microdialysis study in humans. Anesthesiology. 1999;91(4):962.","journal-title":"Anesthesiology"},{"issue":"5 Pt 1","key":"3787_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0190-9622(97)70115-4","volume":"37","author":"MI Singer","year":"1997","unstructured":"Singer MI, Shapiro LE, Shear NH, Cytochrome. P-450 3A: interactions with dermatologic therapies. J Am Acad Dermatol. 1997;37(5 Pt 1):765\u201371.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3787_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/jvp.12695","volume":"41","author":"LR Soma","year":"2018","unstructured":"Soma LR, You Y, Robinson MA, Boston RC. Pharmacokinetics of intravenous, subcutaneous, and topical administration of lidocaine hydrochloride and metabolites 3-hydroxylidocaine, monoethylglycinexylidide, and 4-hydroxylidocaine in horse. J Vet Pharmacol Ther. 2018;41(6):825\u201337.","journal-title":"J Vet Pharmacol Ther"},{"issue":"6","key":"3787_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1046\/j.1365-2885.1998.00165.x","volume":"21","author":"JD Harkins","year":"1998","unstructured":"Harkins JD, Mundy GD, Woods WE, et al. Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings. J Vet Pharmacol Ther. 1998;21(6):462\u201376.","journal-title":"J Vet Pharmacol Ther"},{"issue":"11","key":"3787_CR8","first-page":"1894","volume":"49","author":"LR Soma","year":"1988","unstructured":"Soma LR, Behrend E, Rudy J, Sweeney RW. Disposition and excretion of flunixin meglumine in horses. Am J Vet Res. 1988;49(11):1894\u20138.","journal-title":"Am J Vet Res"},{"key":"3787_CR9","doi-asserted-by":"publisher","first-page":"984108","DOI":"10.3389\/fvets.2022.984108","volume":"9","author":"J Minuto","year":"2022","unstructured":"Minuto J, Bedenice D, Ceresia M, Zaghloul I, B\u00f6hlke M, Mazan MR. Clinical effects and pharmacokinetics of nebulized lidocaine in healthy horses. Front Vet Sci. 2022;9:984108.","journal-title":"Front Vet Sci"},{"issue":"2","key":"3787_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2344\/0003-3006(2008)55[40:POLWEF]2.0.CO;2","volume":"55","author":"PA Moore","year":"2008","unstructured":"Moore PA, Hersh EV, Papas AS, et al. Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylate. Anesth Prog. 2008;55(2):40\u20138.","journal-title":"Anesth Prog"},{"issue":"10","key":"3787_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/bja\/44.10.1040","volume":"44","author":"DB Scott","year":"1972","unstructured":"Scott DB, Jebson PJ, Braid DP, Ortengren B, Frisch P. Factors affecting plasma levels of lignocaine and prilocaine. Br J Anaesth. 1972;44(10):1040\u20139.","journal-title":"Br J Anaesth"},{"issue":"4","key":"3787_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2746\/042516408X284664","volume":"40","author":"EJ Dickey","year":"2008","unstructured":"Dickey EJ, McKenzie HC, Brown KA, de Solis CN. Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses. Equine Vet J. 2008;40(4):348\u201352.","journal-title":"Equine Vet J"},{"issue":"5","key":"3787_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1213\/ANE.0000000000000936","volume":"121","author":"SJGM Ahlers","year":"2015","unstructured":"Ahlers SJGM, V\u00e4litalo PAJ, Peeters MYM, et al. Morphine glucuronidation and elimination in intensive care patients: a comparison with healthy volunteers. Anesth Analg. 2015;121(5):1261\u201373.","journal-title":"Anesth Analg"},{"issue":"2","key":"3787_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF01062338","volume":"15","author":"AH Thomson","year":"1987","unstructured":"Thomson AH, Elliott HL, Kelman AW, Meredith PA, Whiting B. The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects. J Pharmacokinet Biopharm. 1987;15(2):101\u201315.","journal-title":"J Pharmacokinet Biopharm"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03787-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:03:15Z","timestamp":1698649395000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03787-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03787-x","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the University of California Davis Animal Care and Use Committee. All procedures were carried out in accordance with relevant guidelines and regulations when applicable. ARRIVE guidelines were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}